Agile Implementation of Innovative End to End Technical Solutions for Respiratory Testing in the COVID-19 Pandemic. 2021

Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
Intermountain Healthcare, Salt Lake City, Utah.

The COVID-19 pandemic required rapid implementation testing at large scale. We describe our approach to creating an efficient and highly scalable end-to-end testing and reporting workflow. We utilized a combination of consumer-driven workflows, a consistent ordering and data collection EMR user interface, an EMR independent entry point for affiliated providers, and rapidly evolving automation of screening, registration, patient identification, curbside specimen management, and prioritization logic. Our agile approach allowed us to transition from people-driven processes and gain efficiencies utilizing previously developed informatics infrastructure, new solutions and emerging consumer digital tools. We supported over 1,000,000 tests with >200 prioritization logic changes without requiring education or changing the provider ordering workflows, handled patient-driven screening, data collection, and ordering of up to 9 patients/minute while decreasing curbside specimen collection from more than 39 to less than 17 minutes per patient. The approach supported texting consumers and standards-based reporting to public health agencies.

UI MeSH Term Description Entries
D011634 Public Health Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. Community Health,Environment, Preventive Medicine & Public Health,Environment, Preventive Medicine and Public Health,Health, Community,Health, Public
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D057188 Workflow Description of pattern of recurrent functions or procedures frequently found in organizational processes, such as notification, decision, and action. Work Flow,Work Flows,Workflows
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
March 2021, Journal of general and family medicine,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
September 2021, Nanotechnology,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
May 2022, Acta bio-medica : Atenei Parmensis,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
November 2020, Cureus,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
January 2022, Empirical software engineering,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
February 2021, Indian journal of orthopaedics,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
May 2020, China CDC weekly,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
January 2020, Frontiers in public health,
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
March 2023, Lancet (London, England),
Tamara Moores Todd, and Kathryn G Kuttler, and Diego Ize-Ludlow
January 2024, American journal of disaster medicine,
Copied contents to your clipboard!